GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps biotech companies conduct clinical trials. Its stock price reflects the volume of venture capital funding in the biotech sector and the outsourcing of R&D by big pharma, which drives high demand for its services.
Share prices of companies in the market segment - Pharma tests
Medpace is a contract research organization (CRO) providing clinical trial services to biotech and pharmaceutical companies. We classify it as a pharmaceutical testing company. The chart below shows the dynamics of this sector, driven by R&D outsourcing.
Broad Market Index - GURU.Markets
Medpace is a contract research organization (CRO) that provides a full range of clinical trial services for pharmaceutical and biotech companies. As a key partner for the pharmaceutical industry, it is included in the GURU.Markets index. The chart below shows the overall market performance. Compare its stock to the overall trend.
Change in the price of a company, segment, and market as a whole per day
MEDP - Daily change in the company's share price Medpace Holdings Inc.
For Medpace, a contract research organization, daily price changes are a measure of its response to R&D activity in the biotech sector. While the graph of these fluctuations is unspectacular, they are an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma tests
Medpace Holdings, Inc. is a contract research organization (CRO). This chart shows the average daily volatility of the healthcare sector. Compared to the dynamics of MEDP, whose revenue depends on the R&D budgets of biotech companies, it becomes a barometer of innovation in the pharmaceutical industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Medpace is a contract research organization (CRO) providing clinical trial services to biotech and pharmaceutical companies. Its business serves as a barometer of activity in the global pharmaceutical industry. The chart below shows general market fluctuations, which can be used to assess the sector's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its annual growth rate serves as a barometer of R&D investment in the biotech industry. The chart below tells the story of this science-intensive business.
Annual dynamics of market capitalization of the market segment - Pharma tests
Medpace Holdings, Inc. is a contract research organization (CRO) that helps biotech companies conduct clinical trials. Its focus on small and mid-sized companies is its key differentiator. The chart below shows how its expertise and growing R&D spending in the pharmaceutical industry are impacting its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Medpace is a contract research organization (CRO) that helps biotech companies conduct clinical trials. The company's growth is fueled by increased investment in biotech.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Medpace Holdings Inc.
The dynamics of Medpace, a contract research organization (CRO), are dependent on the R&D cycles in the biotech industry. The monthly fluctuations on the chart reflect the funding available to small and medium-sized biotech companies, which are its primary clients and hire it to conduct clinical trials.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Medpace Holdings, Inc. is a contract research organization (CRO) providing clinical trial services to small and mid-sized biotech and pharmaceutical companies. Its sector dynamics, shown in the graph, reflect the volume of R&D investments. This allows us to assess how Medpace's focus on a specific client segment and comprehensive approach help it operate effectively.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Medpace is a contract research organization (CRO) that helps biotech companies conduct clinical trials. Its business depends on the flow of biotech investment. The chart below demonstrates how closely Medpace's performance correlated with investor risk appetite, as reflected in the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Medpace Holdings Inc.
The short-term performance of Medpace, a contract research organization (CRO) that facilitates clinical trials, reflects activity in the biotech sector. News of venture capital funding for pharmaceutical startups and the overall volume of R&D spending in the industry are impacting its order book.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Medpace and the entire contract research organization (CRO) sector depend on the overall R&D budgets of the pharmaceutical industry. Growing investment in biotechnology is a driver for everyone. The chart shows how the company competes for share in this growing market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Medpace is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. Its business depends on funding from the biotech sector. This chart shows how sensitive Medpace shares are to sentiment in this innovative industry.
Market capitalization of the company, segment and market as a whole
MEDP - Market capitalization of the company Medpace Holdings Inc.
Medpace's market capitalization is the financial valuation of a contract research organization (CRO) that helps biopharmaceutical companies conduct clinical trials. The chart reflects the demand for R&D outsourcing in the industry. Its growth reflects its successful specialization in small and medium-sized companies and complex therapeutic areas.
MEDP - Share of the company's market capitalization Medpace Holdings Inc. within the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its share of the sector's market capitalization reflects its reputation and growing demand for R&D outsourcing. The chart shows its weight in the industry.
Market capitalization of the market segment - Pharma tests
Medpace is a contract research organization (CRO) that helps biopharmaceutical companies conduct clinical trials. The chart below shows the overall market capitalization of this sector. Its growth reflects the outsourcing of R&D in the pharmaceutical industry. Medpace benefits from the need for efficient and rapid trials.
Market capitalization of all companies included in a broad market index - GURU.Markets
Developing new drugs that generate value requires extensive clinical trials. Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct these trials. Its capitalization is a bet on outsourcing R&D in the pharmaceutical industry.
Book value capitalization of the company, segment and market as a whole
MEDP - Book value capitalization of the company Medpace Holdings Inc.
For Medpace, a contract research organization, this graph is the material foundation of clinical trials. The growth in book value reflects investments in laboratories, offices, and technology platforms around the world. This is the physical infrastructure that helps pharmaceutical companies bring new drugs to market.
MEDP - Share of the company's book capitalization Medpace Holdings Inc. within the market segment - Pharma tests
Medpace Holdings, a contract research organization, has specific assets. Its stake in the sector includes clinical laboratories, trial management offices, and bioanalytical centers. This global physical infrastructure forms the basis for conducting clinical trials for pharmaceutical companies.
Market segment balance sheet capitalization - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps conduct clinical trials for pharmaceutical companies. Their main assets are laboratories, offices, and IT infrastructure. The chart shows that they are less capital-intensive than drug manufacturers, but require a certain scientific foundation.
Book value of all companies included in the broad market index - GURU.Markets
Medpace's assets include clinical laboratories and offices around the world, which provide the physical infrastructure for conducting clinical trials of new drugs. The chart shows how the company expanded its global network to serve biotech and pharmaceutical companies.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Medpace Holdings Inc.
Medpace, as a contract research organization, has offices and laboratories. But its true value lies in its reputation and ability to effectively conduct clinical trials. The chart below shows how the market valued its operational excellence.
Market to book capitalization ratio in a market segment - Pharma tests
Medpace Holdings is a contract research organization that facilitates clinical trials for pharmaceutical companies. Its main assets are its experience and processes. The chart shows the market premium placed on its reputation and efficiency compared to its relatively small tangible assets.
Market to book capitalization ratio for the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. Its main assets are the expertise of its employees and its reputation. Unlike the average valuation in this chart, Medpace's market capitalization is built on its ability to effectively manage complex research, not on its asset holdings.
Debts of the company, segment and market as a whole
MEDP - Company debts Medpace Holdings Inc.
Medpace Holdings, a contract research organization (CRO) that helps biotech companies conduct clinical trials, has a very light capital structure. This chart shows a near-zero debt position. The company's business is based on expertise and services, not capital assets, and is financed through client contracts.
Market segment debts - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. It's a service business whose success depends on expertise and reputation. This chart shows how its financial model differs from that of capital-intensive pharmaceutical giants.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart shows its debt load. The business relies on R&D budgets in the pharmaceutical and biotech industries. A funding cut in this sector could reduce demand for Medpace's services.
Market segment debt to market segment book capitalization - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical drug trials. Success in this business depends on reputation and the ability to effectively manage projects. The chart shows debt trends in the sector, giving investors insight into the financial environment in which Medpace operates.
Debt to book value of all companies in the market
Medpace is a contract research organization (CRO). Its business is less capital-intensive than that of pharmaceutical companies, but requires investment in personnel and technology. This chart shows the average debt across the economy, allowing one to assess how Medpace's financial structure compares to other sectors.
P/E of the company, segment and market as a whole
P/E - Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of new drugs. This chart shows investor sentiment toward R&D outsourcing. High values reflect confidence in the growth of trials, especially among smaller biotech companies.
P/E of the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of their new drugs. They manage the entire process, from design to regulatory approval. This chart shows the average rating for the pharmaceutical trials sector, reflecting R&D activity and investment in new drugs.
P/E of the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart shows the overall sentiment in the healthcare sector, but for MEDP, the level of biotech funding is more important. The company's valuation is a barometer of R&D activity in the pharmaceutical industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart reflects expectations for R&D investment in the healthcare sector. Its trend reflects a bet that clinical research outsourcing will grow, securing Medpace new contracts.
%20P%2FE%20Medpace%20Holdings%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Medpace-Holdings-Inc.&v=1772513842823 "Chart of the company's future (projected) P/E Medpace Holdings Inc.")
Future (projected) P/E of the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) providing clinical trial services to pharmaceutical and biotech companies. This chart shows the company's estimated future revenue in the context of the healthcare sector. It demonstrates investor confidence in its model and the demand for clinical trial outsourcing.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772513842865 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart, which reflects sentiment in the biotech sector, is key for Medpace. Market optimism makes it easier for small pharmaceutical companies to raise funding, which they then use to outsource clinical trials to Medpace.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513842926 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of their drugs. Medpace's success depends on the volume of R&D outsourcing within the pharmaceutical industry. This chart illustrates the profitability of managing the complex drug development process.
Profit of companies in the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps biopharmaceutical companies conduct clinical trials. This chart shows profitability in the pharmaceutical services sector. For MEDP, this is an indicator of R&D activity. Growth here indicates that pharmaceutical companies are actively investing in the development of new drugs.
Overall market profit
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of their drugs. Demand for Medpace's services depends on the level of funding in the R&D sector. This chart provides an overview of the overall market situation, but the key driver is the flow of venture capital into biotech.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. The revenue forecast presented here reflects funding in the biotech sector. Analysts assess Medpace's order book and the demand for R&D outsourcing from the pharmaceutical industry.
%20profit%20of%20the%20company%20Medpace%20Holdings%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Medpace-Holdings-Inc.&v=1772513843006 "Graph of future (projected) profit of the company Medpace Holdings Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. The profit forecast for this sector depends on the level of R&D investment in the pharmaceutical industry. This chart reflects analyst expectations for future drug development activity, which drives the overall CRO market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772513843017 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Medpace is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Its business depends on industry R&D funding. This chart, along with revenue projections, illustrates the investment climate that drives Medpace's new order flow.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513843028 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart shows the high premium investors are paying for its revenue. Rising R&D costs in the pharmaceutical industry are creating strong demand for its services, which is reflected in its high valuation.
P/S market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of new drugs. This chart shows the industry average market capitalization to revenue ratio. It provides insight into how highly the market values Medpace's reputation and the growing demand for clinical research outsourcing.
P/S of the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of new drugs. Its revenue is directly dependent on the volume of R&D investments in the pharmaceutical sector. This chart provides a general market backdrop for assessing investor sentiment toward the sector serving medical innovation.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart reflects investor expectations for the company's future revenue. It is an indicator of R&D activity in the global pharmaceutical industry.
%20P%2FS%20Medpace%20Holdings%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Medpace-Holdings-Inc.&v=1772513843055 "The graph of the company's future (projected) P/S Medpace Holdings Inc.")
Future (projected) P/S of the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Its success depends on the volume of R&D outsourcing in the pharmaceutical industry. This chart reflects how the market evaluates its expertise and ability to effectively manage complex trials.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772513843062 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Their growth depends on the volume of R&D in the industry. This market optimism chart directly impacts Medpace. Economic growth and investor risk appetite provide an influx of funding to biotech, which increases the outsourcing of trials.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513843064 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of their new drugs. This chart shows the level of activity in the R&D sector. Revenue growth is directly related to the volume of clinical trial outsourcing, which, in turn, is driven by biotech industry funding.
Sales of companies in the market segment - Pharma tests
Medpace is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of their new drugs. They provide a full range of services, from protocol development to regulatory filings. Their revenue structure reflects the revenue generated by these complex and long-term research projects.
Overall market sales
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of new drugs. Medpace manages the entire process, from planning to regulatory approval. This total revenue chart includes the healthcare sector, where Medpace accelerates the delivery of life-saving innovations to market.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that provides clinical trial services to biotech and pharmaceutical companies. This chart reflects revenue forecasts, which are directly dependent on the volume of R&D outsourcing in the pharmaceutical industry and the company's ability to attract new projects.
%20sales%20of%20the%20company%20Medpace%20Holdings%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Medpace-Holdings-Inc.&v=1772513843114 "Schedule of future (projected) sales of the company Medpace Holdings Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Medpace is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of new drugs. This chart shows R&D spending forecasts across the pharmaceutical industry. Increased investment in new drug development directly increases demand for the services Medpace provides.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772513843130 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart, which reflects biotech investment forecasts, is important for Medpace. Increased R&D funding directly translates into an increase in the number of clinical trials outsourced to companies like Medpace.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513843152 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Medpace Holdings Inc.
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart demonstrates its high profitability. This profitability is built on providing comprehensive services, expertise in complex therapeutic areas, and effective trial project management.
Market segment marginality - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Profitability depends on scientific expertise and the effective management of complex trials. This chart shows operational results. Their competitive advantage speaks to the high quality of their services and the trust they enjoy from their clients.
Market marginality as a whole
Medpace Holdings is a contract research organization (CRO) that helps biotech companies conduct clinical trials. Its growth is directly dependent on funding in the biotech sector. This overall profitability curve is less important than the appetite for risk and innovation among venture capitalists and large pharma companies.
Employees in the company, segment and market as a whole
Number of employees in the company Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of new drugs. This graphic shows a large team of physicians, scientists, and project managers who organize and oversee the entire complex process of human drug testing—from study design to data analysis.
Share of the company's employees Medpace Holdings Inc. within the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. This chart illustrates its scientific and organizational scale. It reflects the significant share of physicians, scientists, and clinical trial managers within the CRO industry that Medpace represents in managing complex trials.
Number of employees in the market segment - Pharma tests
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials of new drugs. This chart shows the growing number of scientists, physicians, and project managers who manage the complex drug testing process, accelerating their time to market.
Number of employees in the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Activity in this area depends on the volume of R&D funding. The growth in overall employment, reflected in this chart, indicates a healthy economy where investors are willing to invest in risky but promising biotech startups, like Medpace's clients.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Medpace Holdings Inc. (MEDP)
Medpace Holdings is a contract research organization (CRO) that facilitates clinical trials. This chart illustrates a model based on human capital. Low capitalization per employee is typical for CROs, where revenue is directly dependent on the number of scientists, physicians, and managers working on projects for pharmaceutical companies.
%20of%20the%20company%20Medpace%20Holdings%20Inc.%20(MEDP)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Medpace-Holdings-Inc.-MEDP&v=1772513843359 "Chart of market capitalization per employee (in thousands of dollars) of the company Medpace Holdings Inc. (MEDP)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Medpace Holdings (MEDP) is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. It's a service business, where the most important asset is the experience and qualifications of its employees. This chart shows the industry average. It measures the market value generated by each Medpace specialist managing complex trials.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772513843431 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical and biotech companies conduct clinical trials. In this service, value is created by people and processes. This chart shows how the market values the expertise of its scientists and project managers in effectively conducting complex trials.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513843476 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Medpace Holdings Inc. (MEDP)
Medpace (MEDP) is a contract research organization (CRO) that helps biotech companies conduct clinical trials. It's a service business, where the "product" is the expertise of thousands of scientists and project managers. This chart shows how effectively the company manages these trials. Profitability depends on the ability to attract projects and effectively utilize the time of its specialists.
%20Chart%20Medpace%20Holdings%20Inc.%20(MEDP)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Medpace-Holdings-Inc.-MEDP&v=1772513843482 "Company Profit Per Employee (in thousands of dollars) Chart Medpace Holdings Inc. (MEDP)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Medpace (MEDP) is a CRO (Contract Research Organization), a company conducting clinical trials for biotech companies. This chart shows the benchmark for "Pharma tests." This "B2B service" has a moderate benchmark. It's a "people-based business," and profit per employee (scientist, manager) depends on project management effectiveness.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772513843515 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Medpace Holdings is a contract research organization (CRO) that helps pharmaceutical companies conduct clinical trials. This chart, reflecting the value of human capital, highlights the specifics of their services. Success depends on the qualifications of their scientists and project managers. The profitability per employee here is a direct indicator of their ability to effectively manage complex research.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513843529 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Medpace Holdings Inc. (MEDP)
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart reflects the value of scientific and regulatory expertise. High revenue per employee is a result of the work of highly qualified physicians and scientists managing complex and expensive studies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Medpace-Holdings-Inc.-MEDP&v=1772513843531 "Sales chart per company employee Medpace Holdings Inc. (MEDP)")
Sales per employee in the market segment - Pharma tests
Medpace (MEDP) is a contract research organization (CRO). They help pharmaceutical companies conduct clinical trials. It's a service business, where their main assets are scientists, doctors, and project managers. This chart shows how effective their team is. It compares how they monetize their expertise (revenue per employee) compared to other CROs.
Sales per employee for the market as a whole
Medpace (MEDP) is a contract research organization (CRO) that helps small and medium-sized biotech companies conduct clinical trials. It's a "people business" of the highest caliber: their team of doctors and scientists manages the most complex medical research. This chart shows the significant revenue generated by this scientific expertise.
Short shares by company, segment and market as a whole
Shares shorted by company Medpace Holdings Inc. (MEDP)
Medpace (MEDP) is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart measures bearish sentiment. Rising shorts on MEDP may signal concerns that biotech startups (their main clients) are cutting R&D budgets due to funding constraints.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Medpace-Holdings-Inc.-MEDP&v=1772513843552 "Short Shares Chart for the Company Medpace Holdings Inc. (MEDP)")
Shares shorted by market segment - Pharma tests
Medpace (MEDP) is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart highlights the general skepticism in the biotech sector. It summarizes downward price trends, reflecting investor concerns about a slowdown in R&D funding, which is reducing demand for CRO services.
Shares shorted by the overall market
Medpace Holdings (MEDP) is a contract research organization (CRO) that helps biotech companies conduct clinical trials. This chart measures the overall level of pessimism. When market fears rise, investors worry: will venture capital funding dry up for biotech companies, MEDP's primary clients? The company's resilience is a bet on the continuity of medical R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Medpace Holdings Inc. (MEDP)
Medpace is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Their success is based on outsourcing R&D. The chart shows how much investors (above 70) believe in a biotech boom, or how much (below 30) concerns about shrinking R&D budgets (especially at smaller companies) are dampening stocks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Medpace-Holdings-Inc.-MEDP&v=1772513843596 "RSI 14 indicator chart for the company's stock Medpace Holdings Inc. (MEDP)")
RSI 14 Market Segment - Pharma tests
Medpace is a contract research organization (CRO). They help pharmaceutical and biotech companies conduct clinical trials of new drugs, managing the entire process from start to finish. This chart reflects the overall sentiment in the CRO and pharmaceutical services sector. It allows you to see how the market views the R&D outsourcing industry as "overheated" or "undervalued."
RSI 14 for the overall market
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. Their success depends on the sector's R&D budgets. This market sentiment indicator is important because it reflects the health of biotech companies. Euphoria means easy access to capital for R&D, which increases orders for Medpace. Panic dries up funding.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MEDP (Medpace Holdings Inc.)
Medpace Holdings is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials. This chart shows analyst consensus forecasts. Their targets are based on the size of the backlog and overall funding in the biotech sector, which dictates demand for trials.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-MEDP-Medpace-Holdings-Inc.&v=1772513843637 "A chart showing analyst consensus forecasts for the expected stock price. MEDP (Medpace Holdings Inc.)")
The difference between the consensus estimate and the actual stock price MEDP (Medpace Holdings Inc.)
Medpace is a CRO (contract research organization) that manages clinical trials for small and mid-sized biotech companies. This chart shows the difference between the consensus estimate and the price. It illustrates whether analysts believe in a recovery in biotech R&D budgets and whether they see potential for Medpace.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-MEDP-Medpace-Holdings-Inc.&v=1772513843653 "A chart showing the difference between the consensus forecast and the actual stock price. MEDP (Medpace Holdings Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Medpace is a contract research organization (CRO). It helps small and medium-sized biotech companies conduct clinical trials of their new drugs. This chart shows analysts' overall expectations for the entire pharma testing sector. It reflects whether experts believe biotech R&D budgets will grow or decline.
Analysts' consensus forecast for the overall market share price
Medpace Holdings is a CRO (contract research organization). They help biotech companies conduct clinical trials. Their clients are small and medium-sized biotechs. Market expectations, visible on this chart, determine risk appetite. If investors are optimistic, they fund biotechs, which immediately hire Medpace.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Medpace Holdings Inc.
Medpace is a contract research organization (CRO) that helps biotech and pharmaceutical companies conduct clinical trials of new drugs. This chart is a barometer of the biotech industry. Its dynamics reflect the volume of R&D spending in the sector, the number of new drugs entering clinical trials, and the demand for their services to manage complex trials.
AKIMA Market Segment Index - Pharma tests
Medpace is a top-tier CRO (contract research organization), a turnkey company that manages clinical trials for small and medium-sized biotech companies from A to Z. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Medpace's premium (and full-service) model differentiate it from its average CRO competitor?
The AKIM Index for the overall market
Medpace is a contract research organization (CRO) that helps biotech companies conduct clinical trials of their new drugs. This chart, showing the average market value, provides a backdrop. It helps assess how Medpace, whose business relies on R&D budgets in the defense sector, compares to the overall macroeconomic picture, which influences risk appetite.
